Cipher Pharmaceuticals Inc. (CPHRF) Financials

CPHRF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 156.7 million 19.6 million
March 31, 2026 153.8 million 20.6 million
Dec. 31, 2025 156.2 million 30.2 million
Sept. 30, 2025 147.5 million 33.6 million

CPHRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 3.0 million ?
March 31, 2026 4.5 million 304000
Dec. 31, 2025 8.8 million 525000
Sept. 30, 2025 10.7 million 533000

CPHRF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 3.9 million
March 31, 2026 6.2 million
Dec. 31, 2025 13.5 million
Sept. 30, 2025 5.5 million

CPHRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 9.1 million - 124850
March 31, 2026 6.4 million - 428542
Dec. 31, 2025 7.5 million 5.0 million 504606
Sept. 30, 2025 8.4 million 13.0 million 393000

CPHRF Shares Outstanding

No data available :(

CPHRF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 15528 - 3.4 million -
March 31, 2026 987 - 2.9 million 499000
Dec. 31, 2025 25433 - 4.0 million -
Sept. 30, 2025 81000 - 3.7 million 571000

CPHRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 11.8 million 4.0 million
March 31, 2026 12.3 million 4.0 million
Dec. 31, 2025 12.4 million 4.2 million
Sept. 30, 2025 12.8 million 2.3 million

CPHRF

Price: $9.70

52 week price:
7.47
15.00

Earnings Per Share: 0.67 USD

P/E Ratio: 16.42

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 244.5 million

Links: